It recorded a net loss of $121,182.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2019
Oct 31, 2018
|
FY 2018
Jan 31, 2018
|
FY 2017
Jan 31, 2017
|
FY 2016
Jan 31, 2016
|
FY 2016
Jan 31, 2015
|
FY 2012
Jan 31, 2013
|
FY 2011
Jan 31, 2012
|
|---|---|---|---|---|---|---|---|
| Research and development |
—
|
0
|
—
|
—
|
—
|
—
|
0
|
| Selling, general and administrative |
2
+142.6%
|
0
-78.4%
|
2
+5121.0%
|
8
|
0
|
0
-73.2%
|
0
|
| Operating income |
-4
-183.5%
|
-1
+82.6%
|
-6
-5027.2%
|
-10
|
-0
|
—
|
—
|
| Net income |
-7
-1011.4%
|
-0
+98.1%
|
-6
-456.1%
|
-10
|
-1
|
0
-75.9%
|
1
|
| Basic EPS |
—
|
—
|
—
|
-0.11
|
-0.10
|
—
|
—
|
| Diluted EPS |
—
|
—
|
—
|
-0.11
|
-0.10
|
—
|
—
|
| Other measures | |||||||
| Depreciation and amortization |
—
|
—
|
0
-21.3%
|
0
|
0
|
—
|
—
|
| EBITDA |
—
|
—
|
-6
-5044.8%
|
-10
|
-0
|
—
|
—
|
| Interest coverage |
-14.45x
|
-38.31x
|
-516.56x
|
-159.07x
|
-1.81x
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BETRF (OTC)
- Fiscal year ends
- January 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Vancouver, British Columbia, Canada
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1464165
- Former names
- Pivot Pharmaceuticals Inc. (until Dec 3, 2019); Neurokine Pharmaceuticals Inc. (until Mar 26, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.